Xponentia extends PE funding to In Vitro Diagnostics firm Medsource Ozone

By Joseph Rai

  • 12 Jan 2022
Premium
Credit: Pexels

Xponentia Capital has invested in an In Vitro Diagnostics (IVD) manufacturer Medsource Ozone Biomedicals Pvt. Ltd, a top executive......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Become a Premium member
Already a member? Click here to log in.